SARS-CoV2 Virus Origins Report – Only Beginning Of Process Says WHO; 14 Member States Call For More Transparency 30/03/2021 Elaine Ruth Fletcher The most important takeaway about the just-released WHO report on the origins of the SARS-CoV2 virus that has infected over 100 million people to date may not be its initial findings, which need to be held under the microscope, but the fact that it has been issued at all. Speaking at a press conference on […] Continue reading -> ‘All Hypotheses Open’ Says WHO Director General Of SARS-CoV2 Origins Investigation 29/03/2021 Elaine Ruth Fletcher All four original chains of query remain on the table in terms of the origins of the SARS-CoV2 virus, said WHO Director General Dr Tedros Adhanom Ghebreyesus at a press briefing on Monday. But his comments appear to contradict the leaked conclusions of the investigation which point towards a natural cause for the virus emergence […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘All Hypotheses Open’ Says WHO Director General Of SARS-CoV2 Origins Investigation 29/03/2021 Elaine Ruth Fletcher All four original chains of query remain on the table in terms of the origins of the SARS-CoV2 virus, said WHO Director General Dr Tedros Adhanom Ghebreyesus at a press briefing on Monday. But his comments appear to contradict the leaked conclusions of the investigation which point towards a natural cause for the virus emergence […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Israel’s ‘Living Laboratory’ – Vaccines Offer Hope At End Of Coronavirus Tunnel 12/03/2021 Elaine Ruth Fletcher JERUSALEM – One year after the COVID-19 global health emergency was termed a “pandemic” by the World Health Organization – new vaccines are showing their power and efficacy through sharp declines in case rates in Israel – as well as in the United Kingdom and the United States – the second and third countries in […] Continue reading -> As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As European Medicines Agency Approves One-Shot Johnson & Johnson COVID Vaccine – US Has Surplus & Africa A Dearth of Doses 11/03/2021 Elaine Ruth Fletcher & Raisa Santos With the European Union Medicines Agency (EMA) approval Thursday of Johnson and Johnson’s one-shot COVID-19 vaccine, it now remains to be seen which countries and regions will be the first in line for distribution of the one-jab vaccine. Along with its comparatively low-cost, and ease of storage, the one-shot vaccine could be particularly important to […] Continue reading -> COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Summit: Largest Manufacturing Scaleup World Has Ever Seen Presents Big Challenges – No Easy Fixes 09/03/2021 Kerry Cullinan & Elaine Ruth Fletcher A two-day summit of the world’s top pharma and public health sector players to address COVID-19 vaccine supply chain and manufacturing bottlenecks ended on Tuesday with agreement that large vaccine manufacturing scale up potential exists – even in 2021 – but the route is complex and there are no easy fixes. And most immediately, there […] Continue reading -> Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Patents ‘Not’ The Main Barrier To Equitable Vaccine Rollout – Two Leading Vaccine Scientists & Pharma Execs At WHO Event 08/03/2021 Elaine Ruth Fletcher The structural barriers to a faster and more equitable COVID-19 vaccine roll-out go far beyond the issue of patents, declared two of the world’s leading vaccine researchers and pharma execs at a WHO event on Monday evening. Sarah Gilbert, developer of the Oxford/AstraZeneca vaccine and Özlem Türeci, chief medical officer of BioNTech, the developer of […] Continue reading -> AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Vaccine Sharply Reduces Symptomatic COVID-19 In Older Adults; India’s ‘Covaxin’ Vaccine Reported To Be 81% Efficacious – First Interim Analysis 03/03/2021 Raisa Santos & Elaine Ruth Fletcher The AstraZeneca/Oxford vaccine can reduce severe COVID-19 in older adults by up to 70%, says a new Public Health England (PHE) study – which offers the first real-world evidence of the effectiveness of the vaccine in preventing serious disease among older adults, following its approval by UK and European regulatory agencies. Findings about the efficacy […] Continue reading -> Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Israel Eyes Collaboration With Europe On Vaccine Production – As Moderna Gears Up For Major Manufacturing Expansion 02/03/2021 Elaine Ruth Fletcher JERUSALEM – A three-way collaboration between Israel, Austria and Denmark to expand COVID vaccine manufacturing capacity may be taking shape – just as Moderna gears up for a major global manufacturing expansion and the Israeli-based firm, Teva Pharmaceuticals, negotiates with vaccine manufacturers about ways to support more vaccine production and distribution. Austria’s Chancellor Sebastian Kurz […] Continue reading -> Posts navigation Older postsNewer posts